152 filings
Page 4 of 8
8-K
1j4jpqrh
7 May 20
Revance Reports First Quarter 2020 Financial Results, Provides Corporate Update
4:09pm
8-K
fwvhd0s0x41buvclj
24 Feb 20
Revance Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update
4:08pm
8-K
tqiura8p 99r5
14 Feb 20
Entry into a Material Definitive Agreement
5:04pm
8-K
y4o26xefob5fvxfwx
10 Feb 20
Revance Announces Proposed Private Offering of
4:01pm
8-K
bqmakvl5pashk
7 Feb 20
Departure of Directors or Certain Officers
4:12pm
8-K
d4uzslq2
10 Jan 20
Entry into a Material Definitive Agreement
8:11am
8-K
3vhzv93fxlr
9 Jan 20
Revance Provides Corporate Update and Anticipated Milestones for 2020
8:05am
8-K
xuy6aujh
4 Dec 19
Entry into a Material Definitive Agreement
5:09pm
8-K
yo3akgn99qvi
4 Nov 19
Revance Reports Third Quarter 2019 Financial Results, Provides Corporate Update
12:00am
8-K
jbvgjk1ys36g6vq
15 Oct 19
Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne
8:17am
8-K
c689zt1f di25e
27 Aug 19
Entry into a Material Definitive Agreement
8:22am
8-K
rhcjbe 72zfz4yh
5 Aug 19
Revance Reports Second Quarter 2019 Financial Results, Provides Corporate Update
4:08pm
8-K
cdujpo0h6d6dhdh
17 Jul 19
Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors
8:05am
8-K
xmd ru1g1f2p
6 Jun 19
Revance Adds Iconic Brand Builder Jill Beraud to Board of Directors
8:11am
8-K
3b6il555so4wjqmx
8 May 19
Revance Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:08pm
8-K
zpjt53z6vb0vlgd6
15 Mar 19
Departure of Directors or Certain Officers
4:04pm
8-K
01u03v
26 Feb 19
Revance Releases Fourth Quarter and Full Year 2018 Results
4:10pm
8-K
1x50afr39 evmngzltt
25 Jan 19
Departure of Directors or Certain Officers
5:28pm
8-K
2rs65oe 4t9q48uic
17 Jan 19
Entry into a Material Definitive Agreement
7:01am
8-K
2a4nm04z66ai
15 Jan 19
Results of Operations and Financial Condition
4:54pm